Brambles Limited resorts solid result: Is this blue-chip a buy?

There are lots of reasons to buy Brambles Limited (ASX:BXB) but is the price right?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Leading logistics company Brambles Limited (ASX: BXB) has kicked off the week by reporting a solid set of interim results for the half year ended December 31, 2014.

There are two angles worth reviewing Brambles performance from: Actual results and Constant foreign exchange (FX) results. The reason it is good to look at both is that in the first instance it allows an investor to see how much revenue and profit was actually made, while in the second instance an investor can analyse the underlying business performance without the "noise" or effect of what the FX rates did.

Actual FX results

  • Brambles reported revenues of US$2.8 billion which represented a 5% increase
  • Underlying profit came in at US$485 million which equated to a 6% increase

Constant FX results

While the dollar values reported for the current half don't change, the prior corresponding period for comparison do, thereby allowing for a clearer understanding of the business performance.

  • On this basis, revenue increased 8% and underlying profit jumped 10%.
  • Given the headwinds facing Brambles in many of its core markets as a result of difficult consumer and manufacturing environments these results highlight the defensive earnings growth this blue-chip business is capable of achieving.

Here are a few of the key drivers for the business in the recent half:    

  • The group's global pallet operations produced organic growth, modest pricing growth and ongoing new business wins
  • Strong growth rates were achieved in reusable produce crates and intermediate bulk containers
  • Underlying return on invested capital (ROIC) added 0.3% to 16%.

Outlook:

Management has maintained guidance to expect constant current revenue growth of 8% to 9% and an underlying profit of between US$1.055 billion and US$1.085 billion based on FX rates as at the 30 June 2014 and year-on-year growth in underlying ROIC.

The interim dividend was increased by half of one cent to AU14 cents, which bodes well for an increase in the final dividend as well.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned.  

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »